CancerAid valued at $4.25m after welcoming seed funding from strategic investors

By James Harkness · 5 October 2016 · Technology

CancerAid valued at $4.25m after welcoming seed funding from strategic investors

Full details: CancerAid valued at $4.25m after welcoming seed funding from strategic investors

See the complete version on Dynamic Business for the full story and insights.

Read the full article →

Summary

Sydney-based healthtech start-up CancerAid has closed its Seed B funding round at $1.25 million, bringing its total valuation to $4.25 million. Founded in August 2015 by doctors Nikhil Pooviah and Raghav Murali-Ganesh of the Chris O’Brien Lifehouse cancer hospital, the company last month launched an app that manages a patient’s cancer journey, including their treatment and […]